137 related articles for article (PubMed ID: 37017425)
1. Osteomodulin contributes to keloid development by regulating p38 MAPK signaling.
Li Q; Chen H; Liu Y; Bi J
J Dermatol; 2023 Jul; 50(7):895-905. PubMed ID: 37017425
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.
Luo L; Li J; Liu H; Jian X; Zou Q; Zhao Q; Le Q; Chen H; Gao X; He C
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498357
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the EGFR/ERK signaling pathway.
Le X; Fan YF
J Plast Surg Hand Surg; 2023; 57(1-6):129-136. PubMed ID: 34978504
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.
Liang CJ; Yen YH; Hung LY; Wang SH; Pu CM; Chien HF; Tsai JS; Lee CW; Yen FL; Chen YL
Biochem Pharmacol; 2013 Jun; 85(11):1594-602. PubMed ID: 23500539
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts.
Li T; Zhao J
Mol Med Rep; 2018 Mar; 17(3):4057-4061. PubMed ID: 29286129
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.
Daian T; Ohtsuru A; Rogounovitch T; Ishihara H; Hirano A; Akiyama-Uchida Y; Saenko V; Fujii T; Yamashita S
J Invest Dermatol; 2003 Jun; 120(6):956-62. PubMed ID: 12787120
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
8. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
[TBL] [Abstract][Full Text] [Related]
9. TMEM88 inhibits extracellular matrix expression in keloid fibroblasts.
Zhao H; Lu F; Cui S; Zhang X; Wang W; Si E; Yuan Z
Biomed Pharmacother; 2017 Nov; 95():1436-1440. PubMed ID: 28946191
[TBL] [Abstract][Full Text] [Related]
10. Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location.
Zhao MJ; Chen SY; Qu XY; Abdul-Fattah B; Lai T; Xie M; Wu SD; Zhou YW; Huang CZ
Curr Med Sci; 2018 Oct; 38(5):894-902. PubMed ID: 30341526
[TBL] [Abstract][Full Text] [Related]
11. Oleanolic acid regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the TGF-β1/SMAD signaling pathway.
Luo Y; Wang D; Yuan X; Jin Z; Pi L
J Cosmet Dermatol; 2023 Jul; 22(7):2083-2089. PubMed ID: 36847714
[TBL] [Abstract][Full Text] [Related]
12. Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids.
Lee WJ; Ahn HM; Roh H; Na Y; Choi IK; Lee JH; Kim YO; Lew DH; Yun CO
Exp Dermatol; 2015 Aug; 24(8):591-7. PubMed ID: 25865370
[TBL] [Abstract][Full Text] [Related]
13. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
Zhang Y; Cheng C; Wang S; Xu M; Zhang D; Zeng W
Life Sci; 2019 Sep; 232():116637. PubMed ID: 31288014
[TBL] [Abstract][Full Text] [Related]
15. Keloid Core Factor CTRP3 Overexpression Significantly Controlled TGF-
He L; Zhu C; Dou H; Yu X; Jia J; Shu M
Dis Markers; 2023; 2023():9638322. PubMed ID: 37091895
[TBL] [Abstract][Full Text] [Related]
16. Treatment of keloids through Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway.
Lv W; Wu M; Ren Y; Luo X; Hu W; Zhang Q; Wu Y
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200804
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of fibronectin extra domain B suppresses TGF-β1-mediated cell proliferation and collagen deposition in keloid fibroblasts via AKT/ERK signaling pathway.
Cui J; Li Z; Jin C; Jin Z
Biochem Biophys Res Commun; 2020 Jun; 526(4):1131-1137. PubMed ID: 32317186
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL
J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
[TBL] [Abstract][Full Text] [Related]
19. Collagen triple helix repeat containing-1 inhibits transforming growth factor-b1-induced collagen type I expression in keloid.
Li J; Cao J; Li M; Yu Y; Yang Y; Xiao X; Wu Z; Wang L; Tu Y; Chen H
Br J Dermatol; 2011 May; 164(5):1030-6. PubMed ID: 21667528
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of IRF3 inhibits extracellular matrix expression in keloid fibroblasts.
Zhang Y; Zhang L; Lin XH; Li ZM; Zhang QY
Biomed Pharmacother; 2017 Apr; 88():1064-1068. PubMed ID: 28192879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
